Hyperprolactinemia Completed Phase Trials for Cabergoline (DB00248)

Also known as: Hyperprolactinemic disorder / Hyperprolactinaemia / Hyperprolactinemia (disorder)

IndicationStatusPhase
DBCOND0000952 (Hyperprolactinemia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01270711Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)